ERICA ROACH: Open Payments
NPI 1386282655 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 31 payments from 13 companies in 2025. Trend: 2023 $883 · 2024 $1,000 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 5 | $151 |
| Ardelyx, Inc. | 6 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $99 |
| SHIELD THERAPEUTICS INC | 1 | $86 |
| Novo Nordisk Inc | 3 | $66 |
| ANI Pharmaceuticals, Inc. | 3 | $57 |
| Vifor Pharma, Inc. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
Products named: TARPEYO, IBSRELA, JARDIANCE, ACCRUFER, Ozempic, PURIFIED CORTROPHIN GEL, Veltassa, Fabhalta.
Industry payments across KS — which companies pay providers there.
